Global Nucleic Acid Therapeutics Market

Nucleic Acid Therapeutics Market Size, Share, Growth Analysis, By Product (Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi)), By Indication (Autoimmune Disorders, Infectious Diseases), By End-user (Hospitals, Physicians’ Offices), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35A2868 | Region: Global | Published Date: April, 2024
Pages: 210 |Tables: 100 |Figures: 76

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Nucleic Acid Therapeutics Market size was valued at USD 6.7 Billion in 2024 and is poised to grow from USD 7.61 Billion in 2025 to USD 21.12 Billion by 2033, growing at a CAGR of 13.6% during the forecast period (2026–2033).

    The competitive environment of the Global Nucleic Acid Therapeutics Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'Wave Life Science Ltd. (Singapore) ', 'Imugene (Australia) ', 'Aileron Therapeutics Inc. (US) ', 'BioNTech SE (Germany) ', 'Protagonist Therapeutics Inc. (US) ', 'Replicate Bioscience Inc. (US) ', 'Eli Lilly and Company (US) ', 'Copernicus Therapeutics Inc. (US) ', 'Invio Pharmaceuticals Inc. (US) ', 'Benitec Biopharma (Australia) ', 'Alnylam Pharmaceuticals (US) ', 'Zydus Cadila (India) ', 'Excision BioTherapeutics (US) ', 'Pfizer Inc. (US) ', 'Rhythm Pharmaceuticals Inc. (US) ', 'Axcella Health Inc. (US)'

    Advances in molecular technologies and ongoing research on omics have led many companies to invest heavily in it. The nucleic acid-based therapeutics market is highly competitive and market share is gained through multiple business strategies. Acquisitions, partnerships or collaborations are key sources of revenue in the marketplace. For example, in August 2022, Merck & Co. will launch a $1. announced a new therapeutic RNA collaboration with Orna Therapeutics. This collaboration includes the discovery, development and commercialization of novel RNA-based therapies for vaccines, infectious diseases, and oncology programs.

    Increased Investment in Healthcare Services to Increase Market Growth: Increased investment in healthcare has also accelerated the pace of research into many diseases and illnesses. Research efforts to improve health facilities have increased due to the increasing prevalence of genetic abnormalities and chronic diseases in the population.

    North America is predicted to lead the market owing to factors such as high prevalence of chronic diseases such as cancer and diabetes, growing availability of targeted and customized drugs, and supportive government efforts, according to January 2022 CDC National Diabetes Statistical Report More than 130 shows it people in the United States have diabetes. The United States dominates the North American markets.

    Related Reports

    mRNA Therapeutics Market
    Buy Now GET FREE SAMPLE
    Cancer Therapeutics Market
    Buy Now GET FREE SAMPLE
    Gene Therapy Market
    Buy Now GET FREE SAMPLE
    Nucleotide Market
    Buy Now GET FREE SAMPLE
    Protein Therapeutics Market
    Buy Now GET FREE SAMPLE
    Nuclear Medicine Market
    Buy Now GET FREE SAMPLE
    Targeted Therapeutics Market
    Buy Now GET FREE SAMPLE
    Cancer Gene Therapy Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Nucleic Acid Therapeutics Market

    Report ID: SQMIG35A2868

    $5,300
    BUY NOW